SOB full details

Reading File
Finding Sources
Finding Sources
Searching PubMed

dyspnea evaluation management

Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Searching Images

dyspnea shortness of breath diagnostic approach algorithm causes

Reading File
Reading File
Reading File
Reading File
Reading File
I now have a very comprehensive set of content from Harrison's Chapter 39 (the dedicated dyspnea chapter) including mechanisms, mMRC scale, differential diagnosis table, treatment, and distinguishing cardiac from respiratory causes. I have enough to write a thorough, well-organized answer.

Shortness of Breath (SOB) / Dyspnea - Complete Clinical Review

Definition

Dyspnea is defined by the American Thoracic Society as "a subjective experience of breathing discomfort that consists of qualitatively distinct sensations that vary in intensity." It derives from interactions among multiple physiological, psychological, social, and environmental factors. Dyspnea is a symptom - it can only be perceived and self-reported by the patient. Signs of increased work of breathing (tachypnea, accessory muscle use, intercostal retraction) are separate, observable findings.
Key terminology:
  • Dyspnea - the subjective symptom itself
  • Orthopnea - dyspnea worsening when supine
  • Paroxysmal Nocturnal Dyspnea (PND) - severe dyspnea that awakens the patient from sleep
  • Trepopnea - dyspnea in one lateral decubitus position
  • Platypnea - dyspnea that worsens when sitting upright (improves when lying)
(Harrison's Principles of Internal Medicine 22E, Chapter 39)

Epidemiology

  • Present in up to 50% of inpatients and 25% of ambulatory patients
  • Community prevalence: 9-13%, rising to 37% in adults ≥70 years
  • Accounts for 3-4 million emergency visits per year
  • Dyspnea predicts outcomes in COPD better than FEV1 alone (incorporated into GOLD guidelines)
  • Post-COVID syndrome is now an increasingly recognized cause

Mechanisms (Pathophysiology)

Dyspnea can arise via three main pathways:

1. Afferent Signals (Sensory Input to CNS)

  • Chemoreceptors: Peripheral (carotid body, aortic arch) and central (medulla) receptors activated by hypoxemia, hypercapnia, or acidemia → produces "air hunger"
  • Mechanoreceptors:
    • Lungs: stretch receptors, irritant receptors, J receptors
    • Chest wall: muscle spindles and tendon organs
    • Activation by increased airway resistance → "chest tightness" (e.g., asthma, COPD)
    • Reduced lung compliance → "increased effort" (e.g., pulmonary fibrosis)

2. Efferent Signals (CNS to Respiratory Muscles)

Motor commands from the brain to respiratory muscles generate a sense of effort

3. Efferent-Reafferent Mismatch (Most Important)

When the expected motor output does not match the sensory feedback received, dyspnea is magnified. This "neuromechanical uncoupling" is central to many disease states.
(Harrison's, Chapter 39)

Clinical Features and History Taking

When assessing SOB, evaluate 7 key characteristics:
  1. Location (chest tightness vs. throat tightness)
  2. Quality - patient's own words are diagnostic:
    • "Chest tightness / inability to get a deep breath" → Obstructive lung disease (asthma, COPD)
    • "Air hunger / urge to breathe" → Heart failure
    • "Increased effort / heavy breathing" → Neuromuscular disease, deconditioning
    • "Suffocating / choking" → Laryngeal disease, upper airway obstruction
  3. Intensity - mMRC grade (see below)
  4. Temporality - onset, duration, progression
  5. Aggravating factors (exertion, supine position, allergens, smoke)
  6. Alleviating factors (rest, sitting upright, bronchodilators, diuretics)
  7. Associated symptoms (cough, wheeze, fever, leg edema, chest pain, hemoptysis)

Tempo of Onset

OnsetLikely Cause
Acute (minutes)Laryngeal edema, bronchospasm, pulmonary edema, pneumothorax, PE, cardiac ischemia
Subacute (hours-days)Pneumonia, acute bronchitis, worsening heart failure
Chronic/ProgressiveCOPD, IPF, HF, anemia, pulmonary hypertension
Episodic/IntermittentAsthma (triggered by allergens, infections)
(Murray & Nadel's Textbook of Respiratory Medicine; Harrison's)

Special Types of Dyspnea

TypeDescriptionClassic Cause
OrthopneaWorsens when lying supine; improves when uprightLeft heart failure, COPD
PNDAwakens patient at night; forces sitting or standingLeft ventricular failure
Instant orthopneaCannot assume supine position at allBilateral diaphragm paralysis
TrepopneaWorse in one lateral positionLarge pleural effusion, unilateral lung disease
PlatypneaWorse when sitting up, better lying downHepatopulmonary syndrome, ASD (rare)
Exertional dyspneaOnly with activityEarly cardiac or lung disease; deconditioning
(Murray & Nadel's; Goldman-Cecil Medicine)

Differential Diagnosis

Pulmonary and cardiac causes account for up to 85% of all dyspnea cases. Up to one-third of patients have multifactorial causes.

Pulmonary Causes

CategoryExamples
Obstructive airwaysAsthma, COPD, bronchiectasis, upper airway obstruction
ParenchymalIPF, sarcoidosis, pneumonia, pulmonary edema
PleuralPleural effusion, pneumothorax, hemothorax
Chest wall / neuromuscularKyphoscoliosis, ALS, GBS, myasthenia gravis
Pulmonary vascularPulmonary embolism, pulmonary arterial hypertension
MalignancyLung cancer (primary or metastatic), lymphangitic carcinomatosis

Cardiac Causes

CategoryExamples
Systolic dysfunctionHeart failure (HFrEF) post-MI, dilated cardiomyopathy
Diastolic dysfunctionHFpEF, hypertensive heart disease
IschemiaAcute coronary syndrome, angina
Valvular diseaseMitral stenosis/regurgitation, aortic stenosis
PericardialPericardial tamponade, constrictive pericarditis
ArrhythmiaRapid AF, SVT

Other Causes (Non-Cardiopulmonary)

SystemExamples
HematologicSevere anemia, methemoglobinemia, CO poisoning
MetabolicDiabetic ketoacidosis (Kussmaul breathing), thyrotoxicosis
NeuromuscularALS, diaphragm paralysis, Guillain-Barré
PsychologicalAnxiety/panic disorder (hyperventilation), functional dyspnea
DeconditioningObesity, sedentary state (feeling of heavy breathing, need to breathe more)
Post-COVIDPersistent breathlessness syndrome
(Harrison's Table 39-2; Goldman-Cecil Medicine)

Grading Severity: Modified MRC Dyspnea Scale

GradeDescription
0Dyspnea only with strenuous exercise
1Dyspnea on walking slightly uphill or on level
2Walks slower than peers on level; must stop to rest at own pace
3Stops after ~100 m or a few minutes on level ground
4Too breathless to leave house; breathless with ADLs (dressing)
This scale is incorporated into the GOLD COPD severity classification. (Harrison's, mMRC Table 39-1)

Physical Examination

Key findings to look for:
FindingSuggests
Tachypnea, accessory muscle use, retractionsSevere respiratory distress, airflow obstruction
WheezingAsthma, COPD, cardiac asthma
Crackles (bibasilar)Heart failure, pulmonary fibrosis
Absent breath sounds unilaterallyPneumothorax, large effusion
JVD, S3 gallop, peripheral edemaHeart failure
Dullness to percussionPleural effusion, consolidation
Barrel chest, pursed-lip breathingCOPD/emphysema
CyanosisSevere hypoxia
ClubbingIPF, lung cancer, bronchiectasis, cyanotic heart disease
Pulsus paradoxus (>10 mmHg drop on inspiration)Cardiac tamponade, severe asthma

Diagnostic Workup

Initial Studies (for All Patients)

  1. Pulse oximetry - SpO2 assessment (resting, activity, sleep)
  2. Chest X-ray - cardiomegaly, infiltrates, effusion, pneumothorax, hyperinflation
  3. ECG - ischemia, arrhythmia, RV strain (PE), LV hypertrophy
  4. CBC - anemia, leukocytosis (infection)
  5. BNP / NT-proBNP - heart failure screening (excellent sensitivity)
  6. ABG or VBG - hypoxemia, hypercapnia, acidosis

Second-Tier Studies

TestIndication
Pulmonary function tests (PFTs)Distinguish obstructive vs restrictive vs vascular
D-dimer / CT-PASuspected PE
EchocardiogramSystolic/diastolic dysfunction, valvular disease, pericardial disease
High-resolution CT chestParenchymal lung disease (ILD, emphysema, bronchiectasis)
Peak flow / spirometryAsthma, COPD diagnosis
Thyroid function testsThyrotoxicosis
Exercise test (CPET)Unclear etiology despite initial workup

PFT Interpretation in Dyspnea

PatternKey FindingDiagnosis
Obstructive↓ FEV1/FVC, TLC normal/↑, RV ↑COPD, asthma
Restrictive↓ TLC, ↓ FVC, normal FEV1/FVCIPF, chest wall disease, neuromuscular
MixedBoth FEV1/FVC ↓ and TLC ↓Combined disease
DLCO ↓Reduced diffusing capacityEmphysema, IPF, pulmonary HTN
(Symptom to Diagnosis, Table 15-8)

Distinguishing Cardiac vs Respiratory Dyspnea

FeatureCardiacRespiratory
BNPElevatedNormal (unless cor pulmonale)
PFTsNormalObstructive or restrictive
EchoReduced EF, elevated filling pressuresNormal (unless pulmonary HTN)
CXRCardiomegaly, pulmonary vascular congestionHyperinflation, infiltrates, fibrosis
Response to diureticsRapid improvementMinimal effect
CPETHR >85% max, early AT, ↓ O2 pulse, BP drop, ECG changesMax ventilation achieved, ↑ dead space, hypoxemia, bronchospasm
Cardiopulmonary Exercise Test (CPET) is the gold standard when both systems are involved and the cause remains unclear after initial workup. (Harrison's, Chapter 39)

Treatment Principles

1. Treat the Underlying Cause (First Priority)

  • Heart failure → diuretics, ACEi/ARNi, beta-blockers, device therapy
  • Asthma/COPD → bronchodilators, ICS, smoking cessation
  • PE → anticoagulation, thrombolysis
  • Anemia → transfusion, iron replacement
  • Pneumothorax → chest tube / aspiration

2. Supplemental Oxygen

  • Indicated when SpO2 <88% at rest, on activity, or during sleep
  • Improves mortality in COPD with hypoxemia (landmark studies)

3. Pulmonary Rehabilitation

  • Improves dyspnea, exercise capacity, and hospitalization rates in COPD
  • Home/community programs (yoga, Tai Chi) also show positive effects
  • Exercise programs improve outcomes in post-COVID dyspnea

4. Symptom Management (When Cause Not Fully Reversible)

  • Opioids (low dose): Reduce air hunger by suppressing respiratory drive and cortical activity. Benefit is individual; routine use in COPD not supported by recent RCTs (BEAMS trial - JAMA 2022)
  • Anxiolytics: No consistent benefit in studies; use cautiously
  • Fan therapy: Cool air blown across the face stimulates trigeminal receptors and reduces perceived dyspnea - simple, effective palliative measure
  • High-flow nasal oxygen (HFNO): Often used as bridge therapy in malignancy/end-stage disease

5. Palliative Care

In advanced disease (cancer, COPD, heart failure end-stage), dyspnea predicts survival of days to weeks - warrants serious illness conversations, advance directives, and early palliative care referral.

Red Flag Signs (Requiring Urgent/Emergency Evaluation)

  • SpO2 <90% on room air
  • Acute onset at rest
  • Stridor (upper airway obstruction)
  • Absent breath sounds (tension pneumothorax)
  • JVD + muffled heart sounds + hypotension (Beck's triad - tamponade)
  • RR >30/min with accessory muscle use
  • Cyanosis
  • Inability to speak full sentences
  • Associated chest pain (ACS, PE, aortic dissection)

Summary: Bedside Framework for SOB

SOB Patient
 ├── Acute onset → PE, pneumothorax, ACS, flash pulmonary edema, anaphylaxis
 ├── Chronic/progressive → COPD, HF, ILD, anemia, pulmonary HTN
 ├── Episodic → Asthma, anxiety/panic, paroxysmal arrhythmia
 ├── Nocturnal (PND/orthopnea) → Left heart failure
 ├── Exertional only → Early HF, COPD, anemia, deconditioning
 └── At rest → Severe disease, metabolic crisis, psychogenic
Sources:
  • Harrison's Principles of Internal Medicine 22E, Chapter 39: Dyspnea
  • Murray & Nadel's Textbook of Respiratory Medicine, Chapter on Clinical Assessment
  • Goldman-Cecil Medicine, Chapter 39: Approach to Cardiovascular Disease
  • Symptom to Diagnosis: An Evidence-Based Guide, 4th Edition, Chapter 15: Dyspnea
This is a shared conversation. Sign in to Orris to start your own chat.